Dear Dr. Walson

Clin Ther. 2009 Dec;31(12):3021-2; author reply 3022-3. doi: 10.1016/j.clinthera.2009.12.020.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Inhalation
  • Anti-Asthmatic Agents / administration & dosage
  • Anti-Asthmatic Agents / adverse effects
  • Anti-Asthmatic Agents / pharmacokinetics*
  • Double-Blind Method
  • Endpoint Determination
  • Equipment Design
  • Humans
  • Nebulizers and Vaporizers
  • Practice Guidelines as Topic
  • Randomized Controlled Trials as Topic
  • Research Design
  • Therapeutic Equivalency

Substances

  • Anti-Asthmatic Agents